Trial intelligence / Profile preview

Ferinject in anemia after gastrointestinal bleeding

NCT01690585Phase 3Completed

Sponsor
Rouen University Hospital
Start
Jan 2013
Primary completion
Jul 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ferric carboxymaltose in anemia, sponsored by Rouen University Hospital. Started Jan 2013; status: completed.

02

Drugs

ferric carboxymaltose
03

Conditions

anemia

Beyond the preview

Go deeper on NCT01690585.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01690585.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call